• Dorsomorphin (Compound C): Precision Control in AMPK and BMP

  2026-05-13

  Dorsomorphin (Compound C) enables highly selective, dual-pathway inhibition for metabolic, autophagy, and BMP signaling research. Its robust application in both cellular and animal models, combined with methodical troubleshooting strategies, empowers researchers to achieve reproducible results in complex biological systems.

• Breast Cancer Relies on MCL-1’s Canonical Anti-Apoptotic Rol

  2026-05-13

  The referenced study demonstrates that breast cancer cells are primarily dependent on MCL-1 for its canonical anti-apoptotic function, rather than non-apoptotic roles. This finding underscores the therapeutic value of targeting MCL-1 with BH3-mimetic drugs and clarifies mechanistic priorities for apoptosis-based interventions in breast cancer.

• PK/PD Cutoff Determination for Gamithromycin in S. suis Pigl

  2026-05-12

  This study establishes pharmacodynamic targets and PK/PD cutoffs for gamithromycin in treating Streptococcus suis infections in piglets. The findings inform dosing strategies and clinical breakpoint setting, advancing optimization of antibacterial regimens in veterinary settings.

• Birinapant (TL32711): Advancing Apoptosis Induction in Cance

  2026-05-12

  Birinapant (TL32711) empowers translational researchers to overcome apoptosis resistance in cancer models by precisely antagonizing IAP proteins. APExBIO’s product enables robust, reproducible workflows from in vitro assays to in vivo xenografts, with actionable troubleshooting insight for challenging experimental conditions.

• circRNA Regulation of FXR/TLR4 Pathway and Ferroptosis in Ni

  2026-05-11

  This study uncovers a regulatory mechanism involving hsa_circ_0001944, the FXR/TLR4 signaling pathway, and ferroptosis in the context of nickel oxide nanoparticle (NiONP)-induced collagen deposition in hepatic stellate cells. The findings highlight FXR activation as a pivotal intervention point for modulating fibrosis, with implications for metabolic and toxicological liver research.

• Ruxolitinib Triggers Apoptosis and Pyroptosis in Anaplastic

  2026-05-11

  This study demonstrates that Ruxolitinib phosphate (INCB018424) induces both apoptosis and pyroptosis in anaplastic thyroid carcinoma (ATC) by inhibiting JAK1/2-STAT3-driven transcription of DRP1, leading to mitochondrial fission deficiency. These findings uncover a novel regulatory axis linking JAK/STAT signaling, mitochondrial dynamics, and programmed cell death, providing a strong rationale for targeting this pathway in aggressive thyroid cancers.

• Z-WEHD-FMK: Decoding Caspase-1/4/5 Control in Pyroptosis and

  2026-05-10

  Explore how Z-WEHD-FMK, a potent caspase-1/4/5 inhibitor, advances inflammation research by revealing the molecular links between caspase signaling, pyroptosis, and cancer pathogenesis. This article uniquely analyzes the intersection of HOXC8-driven caspase-1 regulation and practical assay optimization.

• Gut Microbiota Mediates PCN Protection in Sepsis-Induced Liv

  2026-05-09

  This study reveals that Pregnenolone-16α-carbonitrile (PCN), a mouse pregnane X receptor agonist, alleviates sepsis-induced liver injury through a gut microbiota-dependent mechanism involving YAP signaling. The findings provide new insight into the gut-liver axis and support translational research on hepatic detoxification and antifibrotic strategies.

• Taltirelin Acetate: Optimizing Neuroprotection and Bioequiva

  2026-05-09

  Taltirelin acetate empowers researchers with selective TRH receptor targeting for neuroprotection, itch, and OSA models. This article demystifies its use in both bench assays and dissolution-driven bioequivalence studies, offering actionable workflows and troubleshooting insights.

• Oligomycin A: Precision Mitochondrial ATP Synthase Inhibitor

  2026-05-08

  Oligomycin A, a gold-standard mitochondrial ATP synthase inhibitor from APExBIO, is redefining experimental design in cancer metabolism and immunometabolic research. Explore protocol enhancements, practical troubleshooting, and the transformative role of Oligomycin A in dissecting metabolic adaptation and apoptosis with data-backed precision.

• Chloroquine (BA1002): Reliable Autophagy Inhibition in Cell

  2026-05-07

  This article synthesizes scenario-driven laboratory challenges and evidence-based solutions using Chloroquine (SKU BA1002), a robust autophagy inhibitor and anti-inflammatory agent for research. It guides biomedical scientists through common pitfalls in cell viability and mechanistic assays, highlighting workflow reproducibility, protocol optimization, and strategic product selection. Explore quantitative data and best practices for maximizing experimental reliability with Chloroquine.

• Tariquidar (XR9576): Precision P-gp Inhibition in Drug Resis

  2026-05-07

  Tariquidar (XR9576) is a potent, selective P-glycoprotein inhibitor that enables precise interrogation of ABC transporter-mediated drug resistance. Its high affinity, unique solubility, and robust selectivity make it a gold standard tool for dissecting chemoresistance mechanisms in complex tumor microenvironments.

• EZ Cap™ Mouse IL-12 mRNA (m1Ψ): Redefining mRNA Immunotherap

  2026-05-06

  Explore how EZ Cap™ Mouse IL-12 mRNA (m1Ψ) advances immunotherapy research by enabling precise, robust cytokine expression with minimized innate immune activation. This comprehensive review highlights unique assay decision points, integrating new delivery science and practical workflow insights.

• Thrombin (Coagulation Factor II) B Chain: Mechanisms & Bench

  2026-05-06

  Thrombin, a trypsin-like serine protease, catalyzes the conversion of fibrinogen to fibrin, activating key coagulation factors and platelets. The APExBIO Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] (A1057) offers verified purity and reliable solubility for research, enabling precise modeling of hemostatic and vascular pathways. This article details its mechanism, evidence base, and critical workflow integration for advanced vascular biology.

• AMPK's Dual Role in Autophagy and Energy Stress: Rethinking

  2026-05-05

  This article examines a recent study overturning the conventional view that AMPK universally promotes autophagy during energy stress. By dissecting complex signaling interactions, the authors reveal that AMPK can inhibit autophagy initiation through ULK1 suppression while preserving autophagic machinery under stress. These findings have significant implications for researchers studying apoptosis, autophagy, and metabolic adaptation.

446 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page